These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 32234136)
21. Propofol-ketamine combination therapy for effective control of super-refractory status epilepticus. Sabharwal V; Ramsay E; Martinez R; Shumate R; Khan F; Dave H; Iwuchukwu I; McGrade H Epilepsy Behav; 2015 Nov; 52(Pt A):264-6. PubMed ID: 26523340 [TBL] [Abstract][Full Text] [Related]
22. Refractory and super-refractory status epilepticus in children and adolescents: A population-based study. Hepsø SW; Lee M; Noszka K; Wollertsen YM; Holmaas G; Kristensen E; Eichele T; Bjork MH; Griffiths ST; Hikmat O Seizure; 2024 Aug; 120():116-123. PubMed ID: 38941802 [TBL] [Abstract][Full Text] [Related]
23. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study. Kantanen AM; Sairanen J; Kälviäinen R Epilepsy Behav; 2019 Dec; 101(Pt B):106413. PubMed ID: 31371204 [TBL] [Abstract][Full Text] [Related]
24. Stiripentol for the treatment of super-refractory status epilepticus. Strzelczyk A; Kortland LM; Knake S; Rosenow F Acta Neurol Scand; 2015 Dec; 132(6):435-9. PubMed ID: 25809474 [TBL] [Abstract][Full Text] [Related]
25. A Comparison of Ketamine and Midazolam as First-Line Anesthetic Infusions for Pediatric Status Epilepticus. Jacobwitz M; Mulvihill C; Kaufman MC; Gonzalez AK; Resendiz K; Francoeur C; Helbig I; Topjian AA; Abend NS Neurocrit Care; 2024 Jun; 40(3):984-995. PubMed ID: 37783824 [TBL] [Abstract][Full Text] [Related]
26. Incidence and mortality of super-refractory status epilepticus in adults. Kantanen AM; Reinikainen M; Parviainen I; Ruokonen E; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Kälviäinen R Epilepsy Behav; 2015 Aug; 49():131-4. PubMed ID: 26141934 [TBL] [Abstract][Full Text] [Related]
27. Ketamine use in the treatment of refractory status epilepticus. Synowiec AS; Singh DS; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM Epilepsy Res; 2013 Jul; 105(1-2):183-8. PubMed ID: 23369676 [TBL] [Abstract][Full Text] [Related]
28. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Gaspard N; Foreman B; Judd LM; Brenton JN; Nathan BR; McCoy BM; Al-Otaibi A; Kilbride R; Fernández IS; Mendoza L; Samuel S; Zakaria A; Kalamangalam GP; Legros B; Szaflarski JP; Loddenkemper T; Hahn CD; Goodkin HP; Claassen J; Hirsch LJ; Laroche SM Epilepsia; 2013 Aug; 54(8):1498-503. PubMed ID: 23758557 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review. Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209 [TBL] [Abstract][Full Text] [Related]
30. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series. DeVine MN; Gordon SE; Press CA J Pediatr Pharmacol Ther; 2023; 28(2):161-166. PubMed ID: 37139250 [TBL] [Abstract][Full Text] [Related]
31. Burden of illness for super-refractory status epilepticus patients. Beg JM; Anderson TD; Francis K; Meckley LM; Fitzhenry D; Foster T; Sukhtankar S; Kanes SJ; Moura LM J Med Econ; 2017 Jan; 20(1):45-53. PubMed ID: 27556834 [TBL] [Abstract][Full Text] [Related]
32. Responsive neurostimulation as a treatment for super-refractory focal status epilepticus: a systematic review and case series. Ernst LD; Raslan AM; Wabulya A; Shin HW; Cash SS; Yang JC; Sagi V; King-Stephens D; Damisah EC; Ramos A; Hussain B; Toprani S; Brandman DM; Shahlaie K; Kanth K; Arain A; Peters A; Rolston JD; Berns M; Patel SI; Uysal U J Neurosurg; 2024 Jan; 140(1):201-209. PubMed ID: 37329518 [TBL] [Abstract][Full Text] [Related]
33. Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population-based study on German health insurance data. Schubert-Bast S; Zöllner JP; Ansorge S; Hapfelmeier J; Bonthapally V; Eldar-Lissai A; Rosenow F; Strzelczyk A Epilepsia; 2019 May; 60(5):911-920. PubMed ID: 30980677 [TBL] [Abstract][Full Text] [Related]
34. Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus. Jacobwitz M; Mulvihill C; Kaufman MC; Gonzalez AK; Resendiz K; MacDonald JM; Francoeur C; Helbig I; Topjian AA; Abend NS Neurology; 2022 Sep; 99(12):e1227-e1238. PubMed ID: 35817569 [TBL] [Abstract][Full Text] [Related]
35. Early polytherapy for benzodiazepine-refractory status epilepticus. Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007 [TBL] [Abstract][Full Text] [Related]
36. Status epilepticus: Refractory and super-refractory. Dubey D; Kalita J; Misra UK Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491 [TBL] [Abstract][Full Text] [Related]
37. Treatment options in pediatric super-refractory status epilepticus. Arayakarnkul P; Chomtho K Brain Dev; 2019 Apr; 41(4):359-366. PubMed ID: 30528076 [TBL] [Abstract][Full Text] [Related]
38. Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany. Strzelczyk A; Ansorge S; Hapfelmeier J; Bonthapally V; Erder MH; Rosenow F Epilepsia; 2017 Sep; 58(9):1533-1541. PubMed ID: 28681418 [TBL] [Abstract][Full Text] [Related]
39. How much refractory is 'refractory status epilepticus'? A retrospective study of treatment strategies and clinical outcomes. Lattanzi S; Giovannini G; Orlandi N; Brigo F; Trinka E; Meletti S J Neurol; 2023 Dec; 270(12):6133-6140. PubMed ID: 37587268 [TBL] [Abstract][Full Text] [Related]
40. The ketogenic diet for super-refractory status epilepticus patients in intensive care units. Park EG; Lee J; Lee J Brain Dev; 2019 May; 41(5):420-427. PubMed ID: 30638692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]